Share
Market Research Report

INDIA AND OMAN PHARMACEUTICAL INDUSTRY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By DrugGeneric · Patented (Branded)
  • By TypePrescription Drugs · Over the Counter Drugs
  • By Drug ClassAnalgesics · Anesthetics · Antibacterials · Antidepressants · Corticosteroids · Nonsteroidal Anti-inflammatory Drugs (NSAIDs) · Anticonvulsants · Antivirals · Anticoagulants · ACE inhibitors · Hormonal agents · Insulin · Contraceptives · Diuretics · Vaccines · Others
  • By ApplicationCardiovascular (Ischemic Heart Disease, Others) · Hypertension · Musculoskeletal · Oncology · Anti-infective · Cirrhosis · Metabolic Disorder(Diabetes, Others) · Weight Management · Central Nervous System · Genito-urinary · Kidney Disease · Gastrointestinal · Respiratory · Hematology · Dermatology · Ophthalmology · Others (Nutraceutical, Dentals, and Gynecology)
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · Online Pharmacies
  • By GeographyIndia and Oman
  • Published In08 Jul 2026
  • Report CodeCMI4569
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug
      • Market Snapshot, By Type
      • Market Snapshot, By Drug Class
      • Market Snapshot, By Application
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Country
      • Market Opportunity Map
  3. India and Oman Pharmaceutical Industry Market

    • Analysis of the Indian Pharmaceutical Industry

      • Drivers & Restraints
      • Market Opportunity
      • Market Trends
      • Impact Analysis
      • Mergers and Acquisitions
      • Epidemiology
      • PEST Analysis
      • SWOT Analysis
      • Regulatory Scenario
      • Reimbursement Scenario
      • Major Indian Exporters/Manufacturers (Global)
      • Major Indian Importers
      • Major Indian Exporters/Manufacturers (To Oman)
      • Indian Pharmaceutical Drugs Import Market
      • Indian Pharmaceutical Drugs Export Market
        • Indian Pharmaceutical Drugs Export to Oman Market
  4. Analysis of the Oman Pharmaceutical Industry

    • Drivers & Restraints
    • Market Opportunity
    • Market Trends
    • Impact Analysis
    • Mergers and Acquisitions
    • Epidemiology
    • PEST Analysis
    • SWOT Analysis
    • Regulatory Scenario
    • Industry Regulations
      • Trade Regulations and Procedures For Export to Oman
      • Trade Barriers (Tariff, Non-tariff, etc.) and Other Entry-level Barriers for Indian Pharma Products in Oman
    • Reimbursement Scenario
    • Major Oman Exporters/Manufacturers (Global)
    • Major Oman Importers
    • Strategy For Indian Pharma Products In Oman
    • India's Strategy For Effectively Entering Oman Pharma Market
    • USP Of Indian Companies In The Oman Pharmaceutical Market And Positioning Strategy
    • Oman Pharmaceutical Drugs Import Market
    • Oman Pharmaceutical Drugs Export Market
      • Oman Pharmaceutical Drugs Export to India Market
    • Ayurvedic Drugs Market
      • Overview of Indian Ayurvedic Drugs
      • Ayurvedic Products by Indian Companies With Certification of Pharmaceutical Product (COPP) Granted As Per WHO-GMP Certification Scheme (1/2)
      • Overview of Oman Ayurvedic Drugs Import
      • Indian Ayurvedic Companies Registered in Oman
    • Strategies Adopted By Local Oman Manufacturers
  5. India and Oman Pharmaceutical Industry Market, By Drug, 2021 – 2033 (USD Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Generic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Patented (Branded)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
  6. India and Oman Pharmaceutical Industry Market, By Type, 2021 – 2033 (USD Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Prescription Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Over the Counter Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million
  7. India and Oman Pharmaceutical Industry Market, By Drug Class, 2021 – 2033 (USD Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Analgesics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Anesthetics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Antibacterials
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Antidepressants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Anticonvulsants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Antivirals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Anticoagulants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • ACE inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Hormonal agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Insulin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Contraceptives
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Diuretics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
  8. India and Oman Pharmaceutical Industry Market, By Application, 2021 – 2033 (USD Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Cardiovascular
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
        • Ischemic Heart Disease
        • Others
    • Hypertension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Musculoskeletal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Anti-infective
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Metabolic Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
        • Diabetes
        • Others
    • Weight Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Central Nervous System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Genito-urinary
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Kidney Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Gastrointestinal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Respiratory
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Hematology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Dermatology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Ophthalmology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Others (Nutraceutical, Dentals, and Gynecology)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
  9. India and Oman Pharmaceutical Industry Market, By Distribution Channel, 2021 – 2033 (USD Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
  10. India and Oman Pharmaceutical Industry Market, By Country, 2021 – 2033 (USD Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2026 – 2033
      • Regional Trends
    • India
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 – 2033 (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 – 2033 (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033 (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 – 2033 (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033 (USD Million)
    • Oman
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 – 2033 (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 – 2033 (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033 (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 – 2033 (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033 (USD Million)
  11. Case Study of Successful Foreign Pharma Product Entries Into Oman Market

    • Case Study of 5 Successful Foreign Pharma Companies Entry Into Oman Market

    • Company Profiles (Global)

      • Pfizer, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Bristol-Myers Squibb Company
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Sanofi S.A.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • F. Hoffmann-La Roche AG
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Bayer AG
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Novartis International AG
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • AbbVie Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • GlaxoSmithKline plc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Eli Lilly and Company
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Zydus Cadila
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Aurobindo Pharma Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Cipla Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Dr. Reddy's Laboratories Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Lupin Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Sun Pharmaceutical Industries Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Serum Institute of India Pvt. Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Biocon Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Strides Pharma Science Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Unichem Laboratories Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
  12. Section

    • Research Methodology
    • About us